Gerresheimer AG, trading as GRRMF on the OTC exchange, is a German company known for its packaging and medical equipment. On October 10, 2025, GRRMF reported its earnings before the market opened. The company posted an earnings per share (EPS) of $0.90, slightly below the estimated EPS of $0.94. Actual revenue was approximately $655.4 million, missing the estimated $767.4 million.
During the Q3 2025 earnings call, CEO Dietmar Siemssen and CFO Wolf Lehmann discussed the company's financial performance. The call, hosted by Guido Pickert, was attended by analysts from major financial institutions. Gerresheimer revised its 2025 outlook downward, anticipating a decline in organic revenues between 2% and 4%, following the disappointing third-quarter results.
Gerresheimer's financial metrics provide insight into its market valuation. The company has a price-to-earnings (P/E) ratio of 24.16, indicating how the market values its earnings. Its price-to-sales ratio is 0.70, suggesting the market value relative to sales. The enterprise value to sales ratio is 0.62, reflecting the company's total value compared to its sales.
The enterprise value to operating cash flow ratio is 5.65, offering insight into the company's valuation in relation to its cash flow. The earnings yield stands at 4.14%, providing a perspective on the return on investment. Additionally, the current ratio is 1.01, indicating Gerresheimer's ability to cover short-term liabilities with short-term assets.
